Panic Disorder
📧 Sign up to get email alerts when something new happens for Panic Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-12FDA Approved: ZOLOFT — Supplemental Application (ROERIG)
The FDA approved a supplemental application for Zoloft (sertraline hydrochloride) submitted by Roerig.
-
FDA approval · 2014-09-11FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approves a supplemental application for Fluoxetine hydrochloride (fluoxetine) from PAI Holdings, LLC dba PAI Pharma.
-
CLINICAL_TRIALS trial_result · 2014-08-21Clinical Trial Update: Quetiapine in Co-Morbid Depressive and Anxiety Disorders [NA]
A completed clinical trial evaluating quetiapine for co-morbid depressive and anxiety disorders, including major depressive disorder, dysthy…
-
FDA approval · 2014-08-11FDA Approved: FLUOXETINE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for a fluoxetine hydrochloride generic product submitted by PAI Holdings (PAI Pharma).
-
FDA approval · 2014-08-08FDA Approved: ALPRAZOLAM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Alprazolam from Mylan Pharmaceuticals Inc., indicating regulatory approval for a supplementa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-07-21Clinical Trial Update: Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants [NA]
This clinical trial update describes a study on attention retraining for anxiety disorder patients who have not responded to antidepressants…
-
FDA label_change · 2014-07-18FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories. The update concerns this generic product's regulatory s…
-
FDA approval · 2014-07-18FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2014-07-18FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride generic from Lannett Company, Inc.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic) from Dr. Reddy's Laboratories Limited. This action approves …
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic venlafaxine product (ANDA 078932). Venlafaxine is indicated…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride, a generic venlafaxine product from Aurobindo Pharma Limited.
-
FDA approval · 2014-07-17FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for Fluoxetine from Aurobindo Pharma Limited, indicating continued approval of this generic produc…
-
FDA approval · 2014-07-16FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. The approval authorize…
-
FDA approval · 2014-07-11FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for fluoxetine from Aurobindo Pharma Limited, authorizing a new generic fluoxetine product under…
-
FDA approval · 2014-06-30FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., marking an approval action un…
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for venlafaxine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2014-06-26FDA Approved: VENLAFAXINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for venlafaxine submitted by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
-
FDA approval · 2014-06-18FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride from Aurobindo Pharma Limited.
-
FDA approval · 2014-06-17FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)
FDA approved a supplemental application for venlafaxine from BluePoint Laboratories under ANDA077653. This action authorizes a generic versi…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Treatment of Panic Disorder: Long Term Strategies [Phase 3]
Phase 3 clinical trial update on long-term treatment strategies for panic disorder with agoraphobia; study completed.
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders [NA]
This clinical trial update reports the completion of a randomized study evaluating a brief, transdiagnostic therapy called False Safety Beha…
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Effectiveness of Intensive Cognitive Behavioral Therapy in Treating Adolescent Panic Disorder and Agoraphobia [Phase 2]
Phase 2 trial evaluated the effectiveness of intensive cognitive behavioral therapy in adolescents with panic disorder and agoraphobia. The …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Telephone-Based Care Management Program for Individuals With Anxiety Disorders [Phase 3]
This Phase 3 trial evaluated a telephone-based care management program for individuals with anxiety disorders, including panic disorder, and…